City
Epaper

BHEL gets over Rs 9,500 crore order from NTPC for Singrauli Super Thermal Project

By IANS | Updated: March 5, 2024 17:10 IST

Chennai, March 5 Power equipment major Bharat Heavy Electricals Ltd (BHEL) has secured a power plant engineering, procurement, ...

Open in App

Chennai, March 5 Power equipment major Bharat Heavy Electricals Ltd (BHEL) has secured a power plant engineering, procurement, and construction (EPC) order of over Rs 9,500 crore from NTPC Ltd.

The order is for the Singrauli Super Thermal Power Project Stage-III (2x800 MW), in Uttar Pradesh.

According to BHEL, the order won in international competitive bidding is for the supply of equipment like boilers, turbines, generators, and associated auxiliaries, along with electrical and control and instrumentation, balance of plant packages, and others.

The scope of the order includes erection and commissioning and civil works.

According to BHEL, the first 800 MW unit will be completed in 50 months and the second unit in 54 months.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

Entertainment"Himachal Government, administration closely monitoring situation": MP Kangana Ranaut on relief efforts in disaster-affected areas

NationalAfter back-to-back incidents, Kerala govt’s healthcare narrative under fire

EntertainmentDeepika Padukone To Janhvi Kapoor: Bollywood Actresses Who Mastered Classical Dance

HealthAfter back-to-back incidents, Kerala govt’s healthcare narrative under fire

EntertainmentShilpa Shetty shares a glimpse of her Sunday binge date with son Viaan in London

Business Realted Stories

BusinessIndia’s engineering excellence powering world’s most advanced sectors: Piyush Goyal

BusinessPrivate capex is on the rise: CII President Rajiv Memani

BusinessIndustry-government collaboration key to solving rare minerals dependencies: CII President

BusinessIndustry ready if US trade deal doesn't materialise: CII President

BusinessPharma firms likely to post 11% growth in sales, EBITDA in Q1FY26: Report